Safety and Efficacy of Rivaroxaban for Extended-Phase Anticoagulation of Patients with Unprovoked or Recurrent Venous Thromboembolism: Real-Life Data from the MAC Project

Venous thromboembolism (VTE) is a major cause of death in the world. After the acute-phase treatment, the optimal duration of anticoagulation is still debatable. The latest guidelines suggest maintaining long-term anticoagulation in patients with cancer-associated thrombosis (CAT) or with unprovoked...

Descripción completa

Detalles Bibliográficos
Autores principales: Bortoluzzi, Cristiano, Bernardi, Enrico, Camporese, Giuseppe, Noventa, Franco, Ceccato, Davide, Tonello, Chiara, Vo Hong, Ngoc, Campello, Elena, Simion, Chiara, Imbalzano, Egidio, Di Micco, Pierpaolo, Callegari, Elena, Simioni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604582/
https://www.ncbi.nlm.nih.gov/pubmed/36295091
http://dx.doi.org/10.3390/life12101657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604582/
https://www.ncbi.nlm.nih.gov/pubmed/36295091
http://dx.doi.org/10.3390/life12101657

Ejemplares similares